Updated HACOR Score Calculator – NIV Failure Risk Assessment
Updated HACOR Assessment
Estimate the risk of noninvasive ventilation (NIV) failure in acute hypoxemic respiratory failure.
Enter the patient's pre-NIV clinical profile once, then record bedside parameters at each assessment time. The baseline modifiers remain constant across serial assessments.
Baseline clinical profile (before NIV)
Serial NIV assessment
Record heart rate, arterial pH, GCS, oxygenation and respiratory rate.
Before NIV initiation
Baseline HACOR measurement.
After 1–2 hours of NIV
Primary time point used in the updated HACOR validation study.
After 12 hours of NIV
Optional serial reassessment.
After 24 hours of NIV
Optional serial reassessment.
About the Updated HACOR Score
The Updated HACOR score combines the original five-variable HACOR score with six pre-NIV clinical variables to improve prediction of NIV failure in adults with acute hypoxemic respiratory failure.
Original HACOR components
| Variable | Value | Points |
|---|---|---|
| Heart rate | ≤120 / ≥121 beats/min | 0 / 1 |
| Arterial pH | ≥7.35; 7.30–7.34; 7.25–7.29; <7.25 | 0; 2; 3; 4 |
| GCS | 15; 13–14; 11–12; ≤10 | 0; 2; 5; 10 |
| PaO₂/FiO₂ (mmHg) | ≥201; 176–200; 151–175; 126–150; 101–125; ≤100 | 0; 2; 3; 4; 5; 6 |
| Respiratory rate | ≤30; 31–35; 36–40; 41–45; ≥46 /min | 0; 1; 2; 3; 4 |
Updated baseline modifiers
| Baseline variable | Points |
|---|---|
| SOFA score | 0.5 × SOFA |
| Pneumonia | +2.5 |
| Cardiogenic pulmonary edema | −4 |
| Pulmonary ARDS | +3 |
| Immunosuppression | +1.5 |
| Septic shock | +2.5 |
Interpretation after 1–2 hours of NIV
| Updated HACOR | Risk category | NIV failure rate |
|---|---|---|
| ≤7 | Low | 12.4% |
| 7.5–10.5 | Moderate | 38.2% |
| 11–14 | High | 67.1% |
| >14 | Very high | 83.7% |
Risk categories and observed failure rates above were reported for the 1–2-hour assessment cohort. They should not be interpreted as an individualized calibrated probability for every patient or every time point.
References
Important limitations
- The updated score was developed and externally validated in hypoxemic respiratory failure; the derivation study excluded hypercapnic respiratory failure, COPD exacerbation, post-extubation NIV and emergency intubation.
- The score supports risk assessment; it does not replace clinical assessment, airway evaluation, hemodynamic monitoring or timely escalation.
- Risk bands are presented as published cohort strata, not as a stand-alone intubation threshold.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.